EUS‐Guided Gallbladder Drainage for Acute Cholecystitis in the Western World: Heterogeneity in Current Practice and the Relation With Patient Outcome
BACKGROUND: Laparoscopic cholecystectomy is the standard treatment for acute cholecystitis (AC), but some patients are unfit for (immediate) surgery. Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) using a lumen-apposing metal stent (LAMS) is increasingly used in this population. OBJECTIVE: This multicenter cohort study aimed to evaluate practice patterns in EUS-GBD across Western centers and to identify factors that influence outcomes. DESIGN: We retrospectively analyzed data from patients undergoing EUS-GBD for AC across 18 centers. Patient-related, procedural and outcome data were collected. The primary outcomes of interest were LAMS-related adverse events (AEs), recurrent biliary disease, recurrent acute cholecystitis, and all-cause mortality. Time-to-event analyses were performed using center-stratified Cox proportional hazards and Fine-Gray competing-risk models to identify LAMS procedural factors associated with clinical outcomes. RESULTS: We included 496 patients with a median follow-up of 176 days (IQR 44-569). Technical and clinical success rates of EUS-GBD were 98.2% and 93.5%, respectively. LAMS-related AEs and recurrent biliary disease occurred in 11.1% and 18.8% of patients, respectively. Transduodenal access was associated with a lower cumulative incidence of LAMS-related AEs compared with transgastric access (SHR 0.42, 95% CI 0.23-0.76, p = 0.004) and lower rates of recurrent biliary disease and recurrent acute cholecystitis during follow-up. Larger LAMS diameters (> 10 mm) were associated with a lower risk of recurrent acute cholecystitis and all-cause mortality. No association between coaxial DPPS placement and improved long-term outcomes could be demonstrated after competing-risk adjustment. Among patients undergoing interval cholecystectomy (N = 46), LAMS-related conversion from laparoscopy to laparotomy occurred in 3 cases (6.5%). CONCLUSIONS: In this large cohort study, transduodenal access route and choice of a large (> 10 mm) LAMS diameter were associated with improved outcomes of EUS-GBD. EUS-GBD may be a feasible option as a bridge to laparoscopic cholecystectomy, with limited risk of conversion to laparotomy. The findings of our study require prospective validation.
Authors
- Michele Amata (ORCID: https://orcid.org/0000-0001-6743-7520)
- Roy L.J. van Wanrooij (ORCID: https://orcid.org/0000-0003-0477-4532)
- Rogier P. Voermans (ORCID: https://orcid.org/0000-0002-9969-019X)
- Koen Robert Beukema (ORCID: https://orcid.org/0000-0003-1058-1323)
- Daniela Scimeca (ORCID: https://orcid.org/0000-0003-4633-7912)
- S Stefanović (ORCID: https://orcid.org/0000-0002-0205-3283)
- Hannah van Malenstein (ORCID: https://orcid.org/0000-0003-0673-0939)
- Willem J. Lammers (ORCID: https://orcid.org/0000-0002-5455-5242)
- Enrique Pérez‐Cuadrado‐Robles (ORCID: https://orcid.org/0000-0001-8254-7453)
- Christophe Snauwaert
- Shirley Jiang (ORCID: https://orcid.org/0000-0003-0164-0619)
- Ellen Deschepper
- Eva Hufkens
- Roberto Di Mitri (ORCID: https://orcid.org/0000-0003-4251-8265)
- Alexander Arlt (ORCID: https://orcid.org/0000-0002-6160-1059)
- Pieter Hindryckx (ORCID: https://orcid.org/0000-0002-5949-2607)
- Alberto Larghi (ORCID: https://orcid.org/0000-0001-7131-3686)
- Elise Devolder
- Niels G. Venneman (ORCID: https://orcid.org/0000-0002-9418-057X)
- Helena Degroote (ORCID: https://orcid.org/0000-0003-1891-0582)
- Cynthuja Thilakanathan
- Wim Laleman (ORCID: https://orcid.org/0000-0002-0842-7813)
- Van der Merwe (ORCID: https://orcid.org/0000-0002-9891-2686)
- Roberto Trasolini (ORCID: https://orcid.org/0000-0001-8059-9807)
- Thomas Billiet
- Michiel Bronswijk (ORCID: https://orcid.org/0000-0003-2039-5022)
- Dennis J. Yang (ORCID: https://orcid.org/0000-0003-3038-4669)
- Anouk G. Overdevest (ORCID: https://orcid.org/0009-0007-0423-9667)
- Emine Gökce (ORCID: https://orcid.org/0009-0000-9840-8650)
- Dominiek De Wulf
- Lionel D’Souza (ORCID: https://orcid.org/0009-0006-8031-2822)
- Natalie Cosgrove
- Muhammad K. Hasan
- Pieter Jan de Jonge
- Kambiz Kadkhodayan (ORCID: https://orcid.org/0000-0002-1279-2960)
- Felice Molinario
- Louis De Wispelaere
- Mustafa Arain
- Maham Hayat
- Douglas G. Adler
- Antonio Pelegrino
- Marco J. Bruno
Institutions
- HOGENT University of Applied Sciences and Arts (BE)
- Université Paris Cité (FR)
- AdventHealth Orlando (US)
- Porter Adventist Hospital (US)
- Universitair Ziekenhuis Leuven (BE)
- AZ Groeninge (BE)
- Ghent University Hospital (BE)
- Stony Brook University Hospital (US)
- Medisch Spectrum Twente (NL)
- Erasmus MC (NL)
- Erasmus Hospital (BE)
- Agostino Gemelli University Polyclinic (IT)
- Vancouver General Hospital (CA)
- Ghent University (BE)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Amsterdam Neuroscience (NL)
- Klinikum Oldenburg (DE)
- AZ Sint-Jan (BE)
- Imelda Hospital (BE)
- AZ Delta (BE)
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
- Cancer Center Amsterdam (NL)
- IEDC-Bled School of Management (SI)
- University of Amsterdam (NL)
Publication Details
- Journal
- United European Gastroenterology Journal
- Published
- 2026-08-13
- DOI
- https://doi.org/10.1002/ueg2.70275
- Primary Topic
- Gallbladder and Bile Duct Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation